OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and Safety of MAO-B Inhibitors Safinamide and Zonisamide in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Laila Aboulatta, Lara Haidar, Ahmed M Abou-Setta, et al.
CNS Drugs (2023) Vol. 37, Iss. 11, pp. 941-956
Closed Access | Times Cited: 7
Laila Aboulatta, Lara Haidar, Ahmed M Abou-Setta, et al.
CNS Drugs (2023) Vol. 37, Iss. 11, pp. 941-956
Closed Access | Times Cited: 7
Showing 7 citing articles:
Molecular pathways: the quest for effective MAO-B inhibitors in neurodegenerative therapy
Mega Obukohwo Oyovwi, Onoriode Andrew Udi, Adedeji David Atere, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Mega Obukohwo Oyovwi, Onoriode Andrew Udi, Adedeji David Atere, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Potassium and calcium channels in different nerve cells act as therapeutic targets in neurological disorders
Qing Qiu, Mengting Yang, Danfeng Gong, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 5, pp. 1258-1276
Open Access | Times Cited: 4
Qing Qiu, Mengting Yang, Danfeng Gong, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 5, pp. 1258-1276
Open Access | Times Cited: 4
Novel Aromatic Heterocycles for Dual MAO A and B Inhibitors: A Promising Strategy for Parkinson's Disease Treatment
Swati, Amir Raza, Bhupendra Singh, et al.
ChemistrySelect (2025) Vol. 10, Iss. 1
Closed Access
Swati, Amir Raza, Bhupendra Singh, et al.
ChemistrySelect (2025) Vol. 10, Iss. 1
Closed Access
Treatment of Motor Symptoms of Parkinson’s Disease
Luca Marsili, Matteo Bologna, Lily Y. Chen, et al.
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 341-363
Closed Access
Luca Marsili, Matteo Bologna, Lily Y. Chen, et al.
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 341-363
Closed Access
Impulse control disorders in Parkinson’s disease: a national Swedish registry study on high-risk treatments and vulnerable patient groups
Mirjam Wolfschlag, Gustav Cedergren Weber, Daniel Weintraub, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-334116
Open Access | Times Cited: 2
Mirjam Wolfschlag, Gustav Cedergren Weber, Daniel Weintraub, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-334116
Open Access | Times Cited: 2
Effects and safety of monoamine oxidase-B inhibitors for early Parkinson’s disease: a network meta-analysis
Yaping Wang, Zhiyun Wang
European Neurology (2024), pp. 1-18
Closed Access | Times Cited: 1
Yaping Wang, Zhiyun Wang
European Neurology (2024), pp. 1-18
Closed Access | Times Cited: 1
Effects of MAO‑B Inhibitors in life quality of Parkinson’s disease patients: a Systematic Review and Meta‑Analysis
Xiaohuan Liu, Jiehua Su, Jieli Zhang, et al.
Behavioural Brain Research (2024) Vol. 480, pp. 115410-115410
Closed Access | Times Cited: 1
Xiaohuan Liu, Jiehua Su, Jieli Zhang, et al.
Behavioural Brain Research (2024) Vol. 480, pp. 115410-115410
Closed Access | Times Cited: 1
